Hengkang Medical Group Co., Ltd. (002219.SZ)

CNY 2.82

(-1.74%)

Market Cap (In CNY)

9.25 Billion

Revenue (In CNY)

3.59 Billion

Net Income (In CNY)

30.77 Million

Avg. Volume

75.85 Million

Currency
CNY
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
1.66-3.19
PE
274.0
EPS
0.01
Beta Value
0.431
ISIN
CNE1000009R5
CUSIP
-
CIK
-
Shares
3700202741.0
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Mr. Liu Jun
Employee Count
-
Website
https://www.hkmg.com
Ipo Date
2008-03-06
Details
Hengkang Medical Group Co.,Ltd provides medical services, pharmaceuticals, health care, and daily chemical products in China and internationally. It operates approximately 11 hospitals. The company also manufactures pharmaceutical products in the areas of analgesia, cold, cough, gynecology, cardiovascular, digestive, and urinary systems. In addition, it offers Chinese herbal medicines, infusion, and hemostasis products, as well as daily chemical products. The company was formerly known as Gansu Duyiwei Biological Pharmaceutical Co., Ltd. and changed its name to Hengkang Medical Group Co.,Ltd in January 2014. Hengkang Medical Group Co.,Ltd. was founded in 2001 and is based in Chengdu, China.